プロトンポンプ阻害薬と抗血小板薬クロピドグレル,プラスグレルの最近の話題  1.PPIと第二世代チエノピリジン抗血小板薬(クロピドグレル,prasugrel)併用に関するPros and Consの歴史的背景を考える

書誌事項

タイトル別名
  • 1. Historical Perspective on the Pros and Cons of Coadministration of Proton Pump Inhibitors with Thienopyridine Antiplatelet Drugs (Clopidogrel and Prasugrel)

この論文をさがす

説明

Proton pump inhibitors (PPI) are frequently prescribed with thienopyridine antiplatelet drugs (clopidogrel and prasugrel) for the prevention of upper gastrointestinal mucosal damages. However, recent studies have casted doubt on this combination, because several retrospective cohort studies have suggested a possible detrimental drug interaction between these drugs, particularly in patients undergoing percutaneous coronary intervention and stenting. Lines of robust in vitro and in vivo evidence have shown that PPIs are potent inhibitors of CYP2C19 activity in human liver microsomes and that PPIs reduce the production of the active metabolite of clopidogrel, thus attenuating its antiplatelet activity in patients. In addition, it is known that genetic polymorphism of CYP2C19 is associated with loss of CYP2C19 enzyme activity and that drug interactions of PPI with CYP2C19 substrate drugs occur only in subjects with the extensive metabolizer phenotype of CYP2C19. Because Asians possess higher allelic frequencies of loss-of-function alleles of this CYP isoform than Caucasians, they may be less susceptible to the drug interactions between PPI and thienopyridines. In contrast to clopidogrel, metabolic activation of prasugrel is not affected by PPIs, because multiple CYP isoforms are involved. At present, no prospective randomized studies have been reported, which provide reliable risk-benefit data for the coadministration of PPI with thienopyridine antiplatelet drugs both in Caucasians and Asians.

収録刊行物

  • 臨床薬理

    臨床薬理 42 (6), 357-360, 2011

    一般社団法人 日本臨床薬理学会

参考文献 (27)*注記

もっと見る

キーワード

詳細情報 詳細情報について

  • CRID
    1390282680344935680
  • NII論文ID
    10030465829
  • NII書誌ID
    AN0025404X
  • DOI
    10.3999/jscpt.42.357
  • ISSN
    18828272
    03881601
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • Crossref
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ